Recurring concern

Inadequate recording of medication prescribing decisions

Pin Get email alerts Request correction

First reported 21 Mar 2014•Latest report 27 Oct 2025

Definition

What this concern includes

Includes deficiencies in records supporting medication prescribing, including recording the rationale for stopping a medicine, cancelling discontinued prescriptions, accurately classifying repeat and acute prescriptions, recording externally requested medicines, and clearly displaying prescription chronology or quantities.

Not included

  • Excludes generic deficiencies in basic clinical record keeping that are not specifically tied to medication prescribing.
  • Excludes medication administration deficiencies where the prescribing record is not the unsafe control.
  • Excludes failures to monitor a named medication hazard when the record-keeping deficiency is not part of the medication prescribing process.
  • Excludes generic communication, staffing, training or investigation failures unless they directly concern the reliability of medication prescribing records.
Reports
28

Distinct published reports

Individual concerns
29

A report can raise multiple concerns

Date range
2014–2025

First to latest report issue date

Stated actions
29

Described in published responses

Reports over time

Reports over time

Reports about this concern issued each year.

* 2026 is projected from reports observed to 7 Sep 2026.

Most frequent recipients

Most frequent recipients

Reports about this concern sent to each recipient.

NHS England5
Department of Health and Social Care3
General Medical Council2
NHS Greater Manchester Integrated Care Board2
NHS Surrey and Sussex Integrated Care Board2
Belmarsh Prison1
Brunswick Ward at Lindridge1
Delamere Medical Practice1
Eden Park Surgery1
Egton Medical Information Systems Limited1
Fitzalan Medical Group1
Grasmere Surgery1
Greater Manchester1
Hywel Dda University LHB1
Isle of Wight NHS Trust1

Concerns and responses across reports

Only concerns grouped under this recurring concern are included. Select any concern, action or position to view the source wording.

  1. Black Country

    AI-generated summary

    Danielle Monique Christina JONES · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Danielle Jones was found unresponsive at home on 13 May 2025 and was confirmed deceased by paramedics. Post-mortem toxicology found high levels of amitriptyline, excess zopiclone and recent substantial cocaine use; the recorded cause was combined multidrug toxicity. The principal concerns were that, despite reported prescription overdoses and concerns raised by a drug and alcohol service, her repeat prescription medication does not appear to have been reviewed and was continued in large quantities at 28-day frequency.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to record clinical rationale for continued repeat prescribing in light of overdose risk

    Wider context from the report

    “5. Although Miss Jones was signposted to Mental Health Services by her GP, her prescription medications do not appear to have been reviewed and the GP surgery continued to prescribed repeat medications in large amounts at 28 day frequency without any further review subsequent to her appointment on 25/2/25. 6. She was issued with repeat prescriptions on 3 occasions subsequent to her appointment on 24th and 25th February 2025 when she self-closed an overdose of prescription medication. 7. On 6/3/25 despite a recent self-reported admitted overdose of prescription medication of ████████ ████████ ████████ Miss Jones was prescribed 8. On 27/3/25 despite a recent self-reported admitted overdose of prescription medication of ████████ ████████ Miss Jones was prescribed Amitriptyline ████████ Diazepam ████████ lamotrigine ████████ mirtazapine ████████ pregabalin ████████ zopiclone 9. On 28/4/25 despite a recent self-reported admitted overdose of prescription medication of ████████ ████████████████████████████████████████ Miss Jones was prescribed ████████ ████████████████████████████████████████████████████████████████████████ ████████████████████████████████████████████████████████████████████████ 10. Miss Jones died on 13/5/25 from the combined toxic effects of a fatal level of amitriptyline along with an excessive amount of zopiclone. 11. The clinical lead at Cranstoun had previously had discussions with the GP about reducing Miss Jones prescription for zopiclone. 12. No medication review appears to have taken place after Miss Jones self-reported overdose of prescribed medication nor after concerns were raised by Cranstoun. 13. GMC Guidance requires a practitioner to prescribe drugs or treatment including repeat prescriptions, only when they have adequate knowledge of the patient’s health and are satisfied that the drugs or treatment serve the patient’s needs and to keep clear, accurate and legible records, reporting the relevant clinical findings, the decisions made. 14. There is no clinical rationale recorded for the continued prescribing of Miss Jones’s repeat medications in terms of managing Miss Jones’s risk of overdose given her recent disclosure e.g. reducing the frequency to 7 days rather than 28 days. 15. There is no evidence of any medication review having taken place after Miss Jones’s disclosure of overdose of prescription medication or prior to her repeat prescriptions being issued on 6/2/25, 27/3/25 or 28/4/25. Her last reported medication review was on 23/8/24. ”

    Source location

    Danielle Monique Christina JONES · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Amend the self-harm follow-up policy to require medication review and consideration of reducing prescription quantities where ongoing risk exists.

    Verbatim wording from the response

    “We will amend our follow up policy to specifically mention the need for medication review at the time of pro-active follow up, and in particular to consider reducing the amount of medication per prescription if there is any ongoing risk of further self-harm and especially with high-risk medications.”

    Source location

    Response from Your Health Partnership Regis Medical Centre
    Page 3 · response
    Published 29 October 2025

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Amend the self-harm risk-assessment template to record medication review discussions, stockpiling, medication safety, prescription quantity, and medication supervision options.

    Verbatim wording from the response

    “We will amend our risk assessment template to include a mental health medication review code and free text advice regarding the following with a free text box to record discussions.”

    Source location

    Response from Your Health Partnership Regis Medical Centre
    Page 3 · response
    Published 29 October 2025

    Open published response
  2. Carmarthenshire and Pembrokeshire

    AI-generated summary

    Susan Margaret Williams · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Susan Margaret Williams was admitted to hospital on 14 July 2019 with suspected sepsis and abdominal pain, later deteriorating and dying from cardiorespiratory failure due to lung fibrosis and cor pulmonale. The principal concerns were the lack of recorded medication prescription times, a potential delay in administering antibiotics, and the absence of equivalent medication timing records on the Accident & Emergency Record Card.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure of the Medication Record to record medication prescription times

    Wider context from the report

    “1. The Medication Record shows the time that the medications are administered, but not the time that they were prescribed. In this case the evidence showed that the antibiotics were administered later than the other medications and there was a conflict between the prescribing clinician and the nurse administering the medications as to whether all of the medications had been prescribed at the same time. The concern in this case related to a potential delay in the administration of the antibiotic medication (considered to be a significant sepsis treatment), there being a period of some 90 minutes between the times entered on the Record for the administration of the analgesia and the anti-emetic. I consider this to be a concern as the lack of a recorded time of prescription highlights the possibility that there is no immediate means of referencing whether a prescribed medication has been administered within a reasonable time of it being prescribed. Although the factual findings in this inquest did not show a causative connection between the delays in the administration of the antibiotics, I consider this to be a concern that may result in a potential future death. ”

    Source location

    Susan Margaret Williams · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Implement completion of an actual administration time on Emergency Department medication cards and prohibit recording “stat” for intravenous antibiotics.

    Verbatim wording from the response

    “In the interim we will implement that the “time to be given” box on the Medication Card (Emergency Department) is always completed with an actual time. Practitioners will be directed not to write “stat”. The time written will be the time when the antibiotic was prescribed, as immediate administration will always be required with intravenous”

    Source location

    Response from Hywel Dda University Health Board
    Page 1 · response
    Published 20 August 2024

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Implement electronic prescribing and medicines administration systems across Welsh hospitals, with timestamped prescribing and administration records and medication task lists.

    Verbatim wording from the response

    “There are inherent risks with hard copy charts and one of the reasons why in September 2021, the Cabinet Secretary for Health and Social Care announced plans to introduce electronic prescribing and medicines administration (EPMA) systems in every hospital in Wales. All health boards are in the process of implementing EPMA solutions in their hospitals and Digital Health and Care Wales has confirmed both EPMA solutions being deployed in Wales record a timestamp for all activities which make alterations or add data to prescribing records. This includes prescribing and administration events. In future prescribing and administration events will therefore be fully auditable.”

    Source location

    Response from Welsh Government
    Page 2 · response
    Published 20 August 2024

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Changes to the nationally approved Emergency Department medication chart must be considered by the national group, not unilaterally by the Health Board.

    Verbatim wording from the response

    “The medication chart in the Emergency Department is a Wales NHS approved chart. Hywel Dda University Health Board is not able to unilaterally change the chart, although it can put forward proposals for variations to the national group. The Learned Coroner will appreciate that this takes quite some time, and we are aware that the issue has been raised with the National Authority directly in a separate, but linked PFD Report.”

    Source location

    Response from Hywel Dda University Health Board
    Page 1 · response
    Published 20 August 2024

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Existing ARK chart features provide mechanisms to record administration times for urgent and scheduled medicines.

    Verbatim wording from the response

    “The information which must be included on prescriptions is set out in regulation 217 of the Human Medicines Regulations 2012 as amended. Whilst there is no requirement for a prescription to contain the time a medicine was prescribed, there are clearly situations in which specifying an exact time for administration is important for the appropriate care of individual patients. The ARK hospital medication administration record which has been”

    Source location

    Response from Welsh Government
    Page 1 · response
    Published 20 August 2024

    Open published response
  3. Essex

    AI-generated summary

    Chloe Anne Tapp · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Chloe Anne Tapp, a 20-year-old with epilepsy and other medical conditions, suffered seizures and respiratory and cardiac arrest on 7 October 2021 and died in hospital on 8 October 2021. The principal concerns included delays transferring her to adult neurology, a telephone consultation despite her being non-verbal, an incorrect and inadequately documented medication tapering regime, and unanswered attempts to obtain clarification. Broader concerns were raised about staffing shortages, unsafe backlogs and difficulties responding to patients and carers within the neurology department.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to record medication tapering regimes in clinical notes

    Wider context from the report

    “No note was made of the tapering regime for the medication change in Chloe’s notes. ”

    Source location

    Chloe Anne Tapp · Prevention of Future Deaths report
    Page 3 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Communicate and reinforce the requirement that medication tapering regimes are recorded in notes and scanned into electronic patient records.

    Verbatim wording from the response

    “It is our usual practice to record tapering regimes in patient notes, and this is the expected standard as set out in our clinical record keeping standards policy. The regime was recorded in the letter to Chloe’s GP dated 8 September 2021, however the related table drawn up by the Consultant should have been included in Chloe’s notes.”

    Source location

    Response from Mid and South Essex NHS
    Page 2 · response
    Published 6 March 2024

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Audit neurology clinic records for record-keeping compliance and conduct quarterly reviews for divisional governance assurance.

    Verbatim wording from the response

    “To ensure adherence to the expected standards we have completed an audit of neurology clinic records during February and March 2024.The results of this audit showed overall good compliance with dictation, headers, footers, and onward referrals. Small deviations that were picked up were fed back to the team and actioned. Audit reviews will continue quarterly to provide assurance to the divisional governance meeting. These are in addition to the Trust wide record keeping audits.”

    Source location

    Response from Mid and South Essex NHS
    Page 3 · response
    Published 6 March 2024

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Conduct a GIRFT review visit to Mid and South Essex NHS Foundation Trust’s neurology department.

    Verbatim wording from the response

    “Having considered your Report and the concerns raised, a GIRFT visit to Mid and South Essex NHS Foundation Trust has been arranged to review the specific situation within their Neurology department.”

    Source location

    Response from NHS England
    Page 2 · response
    Published 6 March 2024

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Many concerns about Chloe’s care fall within the NHS Foundation Trust’s remit rather than NHS England’s national programme or policy remit.

    Verbatim wording from the response

    “In your Report you raise concerns over pressures being placed on neurology departments and that there was a recognised shortage of neurologists amid an increase in demand. This response focuses on the concerns raised relevant to NHS England national programme or policy. Many of your concerns around the quality of care delivered to Chloe sit within the remit of Mid and South Essex NHS Foundation Trust, and I note that you have also addressed your Report to them.”

    Source location

    Response from NHS England
    Page 1 · response
    Published 6 March 2024

    Open published response
  4. Inner North London

    AI-generated summary

    Glenn Anthony LOCKWOOD · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Glenn Anthony Lockwood, a known drug user receiving opiate replacement treatment, was found unresponsive after a suspected overdose on 14 April 2023 and later suffered a cardiac arrest. Despite hospital treatment, he died on 2 June 2023; the inquest concluded that his death was drug related, with mixed drug toxicity recorded as the medical cause. Concerns included whether Pregabalin abuse risks were sufficiently monitored and whether prescribing and record-keeping issues had been fully investigated and addressed.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Possible deficiencies in record keeping for Pregabalin prescriptions

    Wider context from the report

    “(1) Mr Lockwood’s drug treatment provider wrote to his GP in August 2021 to advise caution “with regard to other medicines with potential for abuse.” According to the British National Formulary, Pregabalin should be monitored for “signs of abuse”. The evidence I received did not reassure me that sufficient steps were taken to monitor for signs of Pregabalin abuse, particularly in a patient with known history of drug abuse. (2) The statement received from Mr Lockwood’s GP alluded to the fact that there were possible record keeping and prescribing issues surrounding Mr Lockwood’s prescriptions for Pregabalin. As a result, a Serious Event Analysis was conducted. In response to written queries from me, The Limehouse Practice responded by email on 14 November 2023. That email alluded to potential errors within the Serious Event Analysis and stated that the Serious Event Analysis would be re-opened and revisited. As such, I am not reassured that relevant risks have fully explored and/or any required action(s) taken. ”

    Source location

    Glenn Anthony LOCKWOOD · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Document medication dose or tablet-strength changes and notify patients of those changes.

    Verbatim wording from the response

    “3. If any changes are made in doses of medication or tablet strength, this must be documented in EMIS consultation notes so there is a clearly identifiable rationale for any change. Patients should also be notified of any change in drug dosage / tablet strength.”

    Source location

    Response from The Limehouse Practice
    Page 4 · response
    Published 6 December 2023

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Provide all prescribers with refresher training on EMIS medication history and prescribing dependence-potential medicines.

    Verbatim wording from the response

    “4. Protected Learning Time is to be used to provide refresher training to all prescribers about EMIS prescribing function and how to view previous medication issues / amendments, as well as further training on prescribing drugs with potential for dependence. I have contacted the CGL/RESET consultant and am awaiting a response from them about agreeing a date for training.”

    Source location

    Response from The Limehouse Practice
    Page 4 · response
    Published 6 December 2023

    Open published response
  5. Inner South London

    AI-generated summary

    Juanita Boate Nti · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Juanita Boate Nti had complex congenital diseases and was receiving palliative care at home. She received twenty times the intended morphine dose after the prescription and symptom control plan failed to clearly specify the volume, and the prescription contained two different concentrations. She suffered respiratory arrest and died following an accidental morphine overdose, with concerns also identified about the EMIS prescribing system not offering the relevant morphine strength.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to clearly record prescribed medication strength and administration volume

    Wider context from the report

    “The hospital originally prescribed 120 micrograms of morphine sulphate 6 hourly and dispensed 100 micrograms per ml solution, but the strength and volume to be administered were not clearly recorded on the plan sent to the GP. The mother requested her GP by telephone to continue the prescription. The GP found only one strength of morphine on the EMIS prescription system, 10mg/5ml, confirmed to be the lowest strength available in the British National Formulary. He wrote this in the first line of the prescription and then confusingly further added “100 micrograms per ml solution, 120 micrograms 6hrly”. The pharmacist did not notice that the second line contained a different concentration and dispensed the higher dose without stipulating the volume to be administered. The baby received 3mg instead of the intended 150 micrograms. Whilst both GP and pharmacist made errors in clinical practice and did not contact each other, the error would not have occurred had another strength of morphine been a choice on EMIS. EMIS have been notified and placed the special prescription on its drug data base. The local commissioning group is conducting a project to identify other special prescriptions that are not on EMIS that may pose a similar risk to safety. ”

    Source location

    Juanita Boate Nti · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Discuss liquid morphine safety with London ICB medication-safety representatives and provide regional oversight of action-plan implementation, including communications to GPs and community pharmacists.

    Verbatim wording from the response

    “The London region Controlled Drugs Accountable Officer will also be discussing this issue with all London ICB medications safety representatives and ensure regional oversight of implementation of action plans which will include communications to GPs and community pharmacists.”

    Source location

    Response from NHS England
    Page 2 · response
    Published 6 September 2023

    Open published response
  6. Surrey

    AI-generated summary

    Matthew William Thomas Power · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Matthew William Thomas Power, a 33-year-old man living in supported accommodation, died at a house in Redhill after taking illicit and prescribed drugs over the previous 36 hours; the medical cause of death was recorded as mixed drug toxicity. The concerns identified related to the EMIS prescribing system, including cancelled prescriptions remaining pending, prescriptions being grouped in a way that obscured prescribing history, and difficulty determining what had been prescribed and issued.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure of EMIS prescription records to clearly display the chronology of issued prescriptions

    Wider context from the report

    “2. I heard evidence that the EMIS system appears to group prescriptions into the amount prescribed rather than simply recording when a prescription is issued. In this case there were different entries grouped as 100 tablets, 50 tablets, 30 tablets, and 24 tablets. Consequently, it was not clear to the duty doctor that the most recent prescriptions for co-codamol had been for a shorter course of only █ tablets and as a result █ tablets of co-codamol were prescribed and issued. ”

    Source location

    Matthew William Thomas Power · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure of ended repeat prescriptions to be removed from pending medication-management queues

    Wider context from the report

    “1. The GP practice uses EMIS for patient records and prescribing. From the evidence it appears that when one doctor ends a repeat prescription on EMIS, it remains in the 'pending' Medication Management box of the doctor to whom it was originally sent. Creating the risk, as in this case, that as a pending prescription it is actioned and issued instead of cancelled. ”

    Source location

    Matthew William Thomas Power · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Provide medication views that display prescriptions chronologically by last issue date and allow clinicians to configure grouping.

    Verbatim wording from the response

    “Medications are grouped within the System with the following “view” options: (i) Acute/Repeat; (ii) EMIS Drug Group; (iii) Problem Orientated View; (iv) Acute/Repeat (Alphabetical); or (v) no grouping (as shown in the dropdown option in Fig 2). As a default, medications are displayed as Acute/Repeat, which will show medications in chronological order of date last issued. An individual user of the System can choose which view to use.”

    Source location

    Response from EMIS
    Page 2 · response
    Published 3 July 2023

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Provide Drug History functionality showing medication commencement, modification, ending, and issue-request events.

    Verbatim wording from the response

    “The System has a Drug History function (within the Medication module) which allows users to view the timeline of any actions performed against each medication entry within the patient record by right-clicking on the relevant medication and choosing “Drug History” (as shown in Fig 3). This includes dates and times a course was commenced, modified, or ended, as well as when requests for medication issues were placed (shown below in Fig 4).”

    Source location

    Response from EMIS
    Page 3 · response
    Published 3 July 2023

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Maintain cancellation warnings, workflow task visibility, and restart-or-reject controls for ended repeat prescriptions.

    Verbatim wording from the response

    “When a clinician ends a prescription (including, any repeat prescription) in the Medication module of the System (End Course), this action ends that prescription if there are no outstanding associated Workflow tasks (as discussed in further detail below).”

    Source location

    Response from EMIS
    Page 1 · response
    Published 3 July 2023

    Open published response

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Existing EMIS Web functionality is sufficient to mitigate the identified medication-management risks, so no software developments are required.

    Verbatim wording from the response

    “Based upon the information provided in the Report and our subsequent review, we do not believe there are any software developments that are required in order to mitigate risks relating to this case beyond the”

    Source location

    Response from EMIS
    Page 4 · response
    Published 3 July 2023

    Open published response
  7. Cornwall and Isles of Scilly

    AI-generated summary

    Julie Louise Hancock · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Julie Louise Hancock underwent a right total knee replacement on 2 March 2022, was discharged on 5 March 2022, and died at home on 28 March 2022. Her post-mortem cause of death was pulmonary embolus due to deep vein thrombosis, with immobility following the knee replacement. The concerns included apparent prescription of low-risk thrombosis prophylaxis despite her being assessed as high risk, an unidentified doctor’s prescription of dalteparin that was stopped after one dose, and possible discrepancies between summary and full thrombosis-prevention guidance.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure to identify the prescribing doctor and record prescribing decision-making

    Wider context from the report

    “I enclose the bundle of evidence. At pp A32-A54, you will find what I am told is the Trust’s Guideline Summary for Thrombosis Prevention and Anticoagulation. At p42, following elective knee replacement, it is suggested clinicians may choose any one of Aspirin ████████ for 14 days LMWH for 14 days and anti-embolism stockings Rivaroxaban ████████ once daily for 14 days As matters of fact, I am told Mrs Hancock was prescribed 14 days of aspirin, an apparent error, one unidentified doctor also prescribed Dalteparin which was stopped after a single dose. It is of concern that the doctor cannot be identified and I have no record of the decision-making. At C32, you will find the Trust’s full guidance for drug prophylaxis following elective knee replacement which is taken from its Thrombosis Prevention and Anticoagulation Policy v9.0 dated Feb 2022. It provides: Low risk – Aspirin ████████ daily for 14 days High Risk – Rivaroxaban ████████ daily for 14 days or Dalteparin or Enoxaparin for 28 days plus stockings (until discharge.) ████████ had not seen the full guidance previously despite it having been published for over a year which, as a consultant orthopaedic surgeon, is of concern in itself. █ further said that Mrs Hancock was high risk yet she appears to have been given prophylaxis for a low risk patient because the summary guidelines appear not to reflect accurately the full guidance. ████████, as I understood ███, said that it had been █ practice to prescribe aspirin to all high-risk patients since (at least) February 2022. This raises the question of whether other patients have died from a PE or DVT because of wrongly prescribed prophylaxis that have not been reported to this Office. You will need to consider the position. I have only considered the situation as it came before me, namely, for an elective knee replacement. As I understand the anticoagulation policy will have a much wider reach than that there is an obvious need to consider the implications across all the Trust’s services. ”

    Source location

    Julie Louise Hancock · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report

    Source evidence

    How this respondent position was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    The records identify the prescriber and document the rationale for suspending aspirin and prescribing dalteparin.

    Verbatim wording from the response

    “After discussion with Pharmacy and a review of the ePMA (Electronic prescribing & Medicines Administration) records there is a clear audit trail of who prescribed the Dalteparin and when.”

    Source location

    Response from Royal Cornwall Hospitals NHS Trust
    Page 2 · response
    Published 19 May 2023

    Open published response
  8. Mid Kent and Medway

    AI-generated summary

    Sally-Ann Few · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Sally-Ann Few was found dead at home on 12 March 2022, after being discharged from hospital the previous day with both slow-release and faster-acting morphine; a post-mortem found that she died as a consequence of morphine toxicity. Concerns included the GP prescribing system not showing that Oromorph had been stopped, a discrepancy between inpatient morphine prescriptions that was not reviewed, and poor medical record keeping that did not document decision-making, discussions, or advice.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Failure of the prescribing system to record discontinued Oromorph prescriptions

    Wider context from the report

    “(1) Evidence given at the inquest revealed that the system at the GP practice when examined by the pharmacist at the hospital did not show that the Oromorph prescription had been stopped. ”

    Source location

    Sally-Ann Few · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Investigate how primary-care morphine changes were recorded, communicated and reflected in the Kent Summary of Care Record.

    Verbatim wording from the response

    “The Trust Pharmacy team has contacted representatives of the Kent & Medway ICB Medicines Optimisation team that cover Medway & Swale. They are currently investigating the review process by the pharmacist to understand how the dose and product changes made were recorded and communicated to the GP practice. They are also investigating why these changes did not appear in the Kent Summary of Care Record.”

    Source location

    Response from Medway NHS Foundation Trust
    Page 2 · response
    Published 21 November 2022

    Open published response
  9. East London

    AI-generated summary

    Ghulam Mohammad · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Ghulam Mohammad, an 89-year-old man, was admitted to hospital after an unwitnessed fall and later sustained a head injury in a further hospital fall. His CT head was delayed for four days, and enoxaparin was prescribed and administered before the extent of any intracranial injury was known. The report also identifies inadequate record keeping and omissions in the initial investigation and consultant statement concerning the use of enoxaparin.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Inadequate recording of clinical factors supporting enoxaparin prescribing

    Wider context from the report

    “4. Inadequate record keeping meant that there was no contemporary account of the factors taken into consideration by the doctor or her supervising consultant in prescribing enoxaparin. ”

    Source location

    Ghulam Mohammad · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report
  10. West Sussex

    AI-generated summary

    Paris Alan George Lapper · Prevention of Future Deaths report

    This summary was generated using AI from the published report. Please read the original report for the complete account.

    Report summary

    Paris Alan George Lapper, aged 19, was found deceased in his room at the Wolsey Hotel on 13 August 2020 and was declared deceased at 1125hrs. The post-mortem recorded respiratory depression due to opiate and benzodiazepine toxicity. The report raised concerns that he obtained duplicate prescriptions from multiple providers because providers lacked a central record or mechanism to check prescriptions issued elsewhere, creating a risk of medication misuse and fatal outcomes.

    Read the report on judiciary.uk

    Source evidence

    How this individual concern was interpreted

    PFD Monitor created a concise, searchable interpretation from the report wording shown below.

    PFD Monitor interpretation

    Lack of a central record of issued prescriptions

    Wider context from the report

    “Mr Lapper was a young man who was struggling with mental health issues. He had become dependent on prescribed medication. He had made concerted efforts to obtain prescribed medication, in the lead up to his death, from a number of sources. He was able to obtain medication from the local Community Mental Health Team, his GP and A&E at the local hospital whilst also obtaining prescriptions from a Private Psychiatrist. During the evidence heard at the Inquest it was clear that individuals can very easily manipulate the current prescription system. As there is no central record of what prescriptions have been issued it appears very easy for individuals to play the system and thereby obtain excess medication. This can lead to the risk of an individual abusing the medication that can bring about a fatal outcome. Whilst the GP was made aware of some of the prescriptions that had been issued there is no mechanism in place for any provider to check what the individual has already been prescribed by with other providers before the new prescription is issued. It appears that the NHS and private providers act in isolation. ”

    Source location

    Paris Alan George Lapper · Prevention of Future Deaths report
    Page 2 · concerns

    Open source report

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Fund and support electronic prescribing adoption across NHS trusts, including the remaining trusts.

    Verbatim wording from the response

    “Firstly, there is work underway to support the adoption of electronic prescribing solutions across Trusts, without which information cannot be made available for sharing. Funding has now been provided to support adoption across more than 80% of NHS Trusts so far and work is underway to fund the remaining 20%. This work will conclude by the end of 2024.”

    Source location

    2021-0148-Response-from-NHS-England-and-NHS-Improvement_Published
    Page 2 · response
    Published 18 May 2021

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Define common medicines-information standards and support their adoption across health and care organisations.

    Verbatim wording from the response

    “Secondly, sharing medicines information requires the adoption of common information standards and work is also underway to define the necessary standards with subsequent plans in place to support adoption across health and care organisations, and these standards will be underpinned by the mandate to adopt them. The first early adopters of this programme are due to have these standards in place by the end of this financial year and the work is due to be completed by the end of 2024. This should enable a consolidated view of an individual’s medicines from numerous sources. In the shorter term, the shared record programme aims to deliver a minimum of view access by the end of this year for information that is digitally available now.”

    Source location

    2021-0148-Response-from-NHS-England-and-NHS-Improvement_Published
    Page 2 · response
    Published 18 May 2021

    Open published response

    Source evidence

    How this respondent action was interpreted

    PFD Monitor created a concise, searchable interpretation from the published response wording shown below.

    PFD Monitor interpretation

    Deliver minimum shared-record view access to currently digitally available medicines information.

    Verbatim wording from the response

    “Secondly, sharing medicines information requires the adoption of common information standards and work is also underway to define the necessary standards with subsequent plans in place to support adoption across health and care organisations, and these standards will be underpinned by the mandate to adopt them. The first early adopters of this programme are due to have these standards in place by the end of this financial year and the work is due to be completed by the end of 2024. This should enable a consolidated view of an individual’s medicines from numerous sources. In the shorter term, the shared record programme aims to deliver a minimum of view access by the end of this year for information that is digitally available now.”

    Source location

    2021-0148-Response-from-NHS-England-and-NHS-Improvement_Published
    Page 2 · response
    Published 18 May 2021

    Open published response
Back to top

Data last updated 7 September 2026